|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for screening for malignant neoplasm of breast
ICD-10 (CM) Code and Descriptor
Z12.31 |
Encounter for screening mammogram for malignant neoplasm of breast
This code is considered unacceptable as a principal diagnosis.
|
Z1231 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
84.14%
|
4.65%
|
2.79%
|
1.99%
|
1.56%
|
1.28%
|
1.01%
|
0.76%
|
0.56%
|
0.41%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.31*:
CPT |
Description |
Number of Claims |
Sum Performed |
77067
|
SCR MAMMO BI INCL CAD |
3,610,459
|
3,610,469
|
77063
|
BREAST TOMOSYNTHESIS BI |
3,045,792
|
3,046,798
|
77080
|
DXA BONE DENSITY AXIAL |
330,278
|
330,282
|
76641
|
ULTRASOUND BREAST COMPLETE |
74,542
|
74,960
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
66,376
|
66,473
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
62,916
|
63,143
|
80053
|
COMPREHEN METABOLIC PANEL |
45,082
|
45,082
|
80061
|
LIPID PANEL |
40,422
|
40,424
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
35,267
|
35,273
|
84443
|
ASSAY THYROID STIM HORMONE |
29,494
|
29,513
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
19,650
|
19,654
|
82306
|
VITAMIN D 25 HYDROXY |
15,520
|
15,519
|
G0279
|
TOMOSYNTHESIS, MAMMO |
14,749
|
14,749
|
76642
|
ULTRASOUND BREAST LIMITED |
12,283
|
12,342
|
80048
|
METABOLIC PANEL TOTAL CA |
10,952
|
10,953
|
77065
|
DX MAMMO INCL CAD UNI |
10,647
|
10,651
|
77066
|
DX MAMMO INCL CAD BI |
10,277
|
10,277
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
9,399
|
9,402
|
84439
|
ASSAY OF FREE THYROXINE |
8,671
|
8,673
|
85027
|
COMPLETE CBC AUTOMATED |
8,549
|
8,549
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.31 related to the following DRG Codes:
951
|